GEROPHARM logo — International rapidly growing biotechnological company with...

GEROPHARM

International rapidly growing biotechnological company with all insulin blockbusters in portfolio

Founded 2001 Russia Russia 175 employees Series Unknown Biopharma, Biotechnology +1

General Information

Company Name GEROPHARM
Founded Year 2001
Location Russia Russia +5
Employees 175
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when GEROPHARM moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GEROPHARM

GEROPHARM is a rapidly growing biotechnological company headquartered in Russia. Established in 2001, it is one of the 20 leading Russian manufacturers of pharmaceutical preparations, with a modern industrial sites and a Full-Cycle production approach. Their portfolio includes all insulin blockbusters, positioning them as a significant player in the Biopharma, Biotechnology, and Pharmaceutical industries. The company not only focuses on drug production but also conducts independent studies and invests considerably in R&D. Their commitment to scientific advances and effective management has earned them a strong reputation in the industry. Their last Venture Round investment was on 17 June 2016, with the Russian Direct Investment Fund (RDIF) as the participating investor. Overall, GEROPHARM presents an appealing investment opportunity for venture capitalists seeking exposure to the rapidly evolving biotechnological and pharmaceutical landscape in Russia.

Taxonomy: pharmaceuticals, insulin, R&D investment, brain function restoration, diabetes treatment, Full-Cycle production, active pharmaceutical ingredients, industrial sites, scientific advances, management, Russian company, international growth, market release, independent studies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
17 Jun 2016

GEROPHARM Alternatives & Competitors

GEROPHARM vs

Empowering pharmaceutical innovation with technological expertise, rigorous quality control, and exc...

56 employees
Biotechnology, Pharmaceutical
GEROPHARM vs

Growing as a modern enterprise, we integrate R&D, production, and sales of contemporary Chinese medi...

Series A
11 employees
Health Care, Pharmaceutical
GEROPHARM vs

Enhancing health and wellness through innovative pharmaceutical solutions and comprehensive medical...

501-1000 employees
Pharmaceutical, Retail

FAQ About GEROPHARM

International rapidly growing biotechnological company with all insulin blockbusters in portfolio
GEROPHARM was founded in 2001.
GEROPHARM is headquartered in Russia.
GEROPHARM operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
GEROPHARM has approximately 175 employees.
GEROPHARM has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to GEROPHARM include 江西富祥药业股份有限公司, RC Pharmacy, Ropharma, POLI INDUSTRIA CHIMICA SpA, SoftGroup. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GEROPHARM and 江西富祥药业股份有限公司 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GEROPHARM and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy